Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00455650
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Completed Study of the Effects of Mecamylamine and Varenicline in Schizophrenia
Condition: Cognition in Schizophrenia
Interventions: Drug: Mecamylamine;   Drug: Varenicline;   Drug: Placebo

Indicates status has not been verified in more than two years